The novel approach of this peptide represents a major breakthrough in the handling of type 2 diabetes. Different to existing medications, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatidepeptide008183.thezenweb.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-80808716